|
V29303
|
D-AP5
|
79055-68-8 |
D-AP5 (D-APV) is a selective and competitive NMDA receptor blocker (antagonist) with Kd of 1.4 μM. |
|
V2414
|
NMDAR antagonist 1
|
2220162-06-9 |
NMDAR antagonist 1 is a potent, orally bioavailable, NR2B-selective NMDAR antagonist. |
|
V4661
|
PEAQX
|
459836-30-7 |
PEAQX (also known as NVP-AAM 077) is a novel, potent, orally bioactive and competitive antagonist at the NMDA receptor. |
|
V9932
|
TCN-201
|
852918-02-6 |
TCN-201 is a novel, potent, non-competitive and selective antagonist of NMDA receptors containing the NR2A subunit with a pIC50 of 6.8. |
|
V2708
|
Sarcosine
|
107-97-1 |
Sarcosine [also called N-methylglycine, Sarcosinic acid, Methylaminoacetic acid, Methylglycine]is a competitive inhibitor of the type I glycine transporter (GlyT1) and an N-methyl-D-aspartate receptor (NMDAR) co-agonist. |
|
V8096
|
Radiprodil (RGH-896)
|
496054-87-6 |
Radiprodil, formerly known as RGH-896, is an orally bioavailable and selective NMDA receptors antagonist which was evaluated as potential treatmen of neuropathic pain associated with diabetic peripheral neuropathy (DPNP). |
|
V2505
|
Felbamate (W-554; ADD-03055)
|
25451-15-4 |
Felbamate (also known as ADD-03055),an antagonist at the NMDA-associated glycine binding site,is an anti-epileptic drug used in the treatment of epilepsy. |